Skip to main content
. 2021 Apr 29;12(5):1911–1929. doi: 10.1093/advances/nmab033

TABLE 1.

Effects of daily oral pyridoxine on plasma vitamin B-6 vitamer concentrations in humans1

Dose, mg/d Participants, n Supplementation Period, wk Plasma concentration, nmol/L
Study2 PL PLP PN PNP 4-PA
Edwards et al. (87) 10 6 1 473 ± 333 595 ± 287 ND ND 295 ± 104
Edwards et al. (87) 25 9 1 231 ± 157 631 ± 158 ND ND 371 ± 175
Edwards et al. (87) 100 9 1 1277 ± 678 518 ± 130 268 350 ± 60 1239 ± 464
Edwards et al. (87) 200 9 1 2441 ± 904 623 ± 138 124 269 ± 213 2200 ± 633
Edwards et al. (87) 400 8 1 4764 ± 1664 732 ± 202 389 120 3717 ± 922
Edwards et al. (87) 800 7 1 9484 ± 1616 644 ± 182 4664 245 7085 ± 1528
Bor et al. (88) 40 43 12 700 350 100 NM 1200
Vrolijk et al. (14) 50 6 1 1200 400 400 NM NM
Speitling et al. (85) 300 10 2 140 330 ND NM 190
1

ND, not detected; NM, not measured; PL, pyridoxal; PLP, pyridoxal 5′-phosphate; PN, pyridoxine; PNP, pyridoxine 5′-phosphate; 4-PA, 4-pyridoxic acid.

2

In the Edwards et al. (87) study, values are means ± SDs for all vitamin B-6 vitamers except for PN with all doses and for PNP with 400 and 800 mg/d, where medians are used. In the other studies, values are means for all vitamin B-6 vitamers.